09:53 AM EST - Cipher Pharmaceuticals Inc. : Announced its financial and operational results for the three months ended June 30, 2018. All figures are in U.S. dollars. Total revenue was $7.0 million for Q2 2018, compared to $9.9 million for Q2 2017. Income from continuing operations was $1.9 million, or $0.07 per basic and diluted share, in Q2 2018, compared with income from continuing operations of $4.4 million, or $0.16 per basic and diluted share, in Q2 2017. Cipher Pharmaceuticals Inc.
shares T.CPH are trading unchanged at $3.22.
